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rAdvances in management of complex health problems
raise the expectations of consumers but also increase
the cost of health care. Patients with severe aortic
stenosis and multiple comorbidities not only want to
get their aortic valve replaced with a minimally inva-
sive approach but also want to accomplish this more
safely than with conventional methods. The economic
See page 115
impact of such technologies challenges the provid-
ers who are asked to reduce health care costs.
Commitment to safety while reducing cost makes
this challenge particularly difficult to meet. In this
issue of iJACC, Bagur et al. (1) propose the use of
transesophageal echocardiography (TEE) as a pri-
mary imaging technique for transapical transcathe-
ter aortic valve implantation (TAVI) to obviate the
need for a hybrid operating room with state-of-the-
art fluoroscopic imaging equipment.
The most critical factor with respect to inserting
new percutaneous devices is accurate positioning,
and this also holds true for mitral, tricuspid, and
aortic valves, and endovascular aortic devices. Usu-
ally, radiography (fluoroscopy and angiography) is
the primary imaging modality during device im-
plantation. Echocardiography is frequently used as
an adjunct imaging tool. Computed tomography
(CT), which is critical in preparing for the proce-
dure, is increasingly integrated with intraprocedural
imaging. The fusion of images from various modal-
ities is rapidly evolving with 3-dimensional (3D)
visualization of anatomy and devices. Fluoroscopy
has a large field of view and depicts 3D information
on a 2-dimensional (2D) monitor, whereas echo-
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imits field of view on mostly 2D monitors. Details
f the devices are much better seen on radiographic
maging, whereas noncalcified tissues are better
isualized by ultrasound. As with the cup/glass
nalogy, the observation of fullness can be differ-
ntly determined depending on cup material, shape,
nd angle of viewing. For example, an opaque bone
hina cup examined from the side is better imaged
y radiographic beam, but ultrasonic sound waves
re fine for a paper cup and better if viewed or imaged
rom above. Similarly, the aortic valve hinge points, in
calcified aortic valve or porcelain root, are better
maged radiographically (either by pre-operative CT
r intraoperatively by fluoroscopy), whereas in a non-
alcified valve the imaging is better assessed with TEE
nless more contrast is used for fluoroscopy. At
resent, most TAVI centers have adopted the tech-
ique of positioning the Edwards SAPIEN valve
Edwards Lifesciences, Inc., Irvine, California) at
0-50 (i.e., one-half the valve “aortic” in relation to the
alve hinge points, and one-half “ventricular”) (2–4).
herefore, for a heavily calcified valve the perception
f “half empty” is best determined by fluoroscopy
hen examining the part of the valve above the aortic
alve hinge points, whereas TEE is the better method
or assessing the “half full” part of the ventricular side
f the device in relation to the hinge points and the
itral valve anterior leaflet.
In our early experience with the transapical ap-
roach in animals, we found that TEE was more
seful because of their lack of calcium (2). Similarly,
e also tried intracardiac echocardiography, but the
echnology at that time was neither adequate nor
dvanced enough. Furthermore, we also found this
pproach was not useful in humans. However, once
uman studies commenced, the change occurred
uite rapidly in imaging using C-arms to hybrid
perating rooms, and we found that improved
adiographic techniques proved to be more useful in
any patients than TEE. Indeed, over time, be-
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126cause of the poor visualization with C-arms, for the
Partner Edwards SAPIEN valve trial, C-arms were
disallowed, and patients had to have their imaging
done in either a hybrid operating room or a cathe-
terization lab operating room with adequate airflow
standards (3–5). Intraprocedural TEE with 3D
imaging provides critical information, such as de-
lineating the location of the guidewire in the left
ventricle to ensure that it is not entangled in the
chordae. This was a potential problem in the early
period of transapical procedures. Furthermore, the
aortic and mitral valves can also be well-imaged, in
addition to looking at the 3D images of the leaflets,
and the axis of insertion can be carefully studied. Of
note, Doppler signals are essential for assessing valve
function and device leaflet function, whereas radio-
graphic techniques are not as useful. A caveat, how-
ever, exists for TEE when the calcium load is high in
the leaflets or the root is calcified or there is moderate-
to-severe mitral annular calcification, particularly an-
teriorly, involving the anterior mitral valve leaflet or
the left coronary or noncoronary sinus, because in
these situations ultrasound visualization is suboptimal.
By contrast, when there is little calcification of the
aortic valve leaflets or annulus, then fluoroscopy might
be inadequate for examining the aortic root unless
repeated injections of contrast are used during the
procedure. In this latter situation, injection of the
aortic root with a pigtail catheter with contrast during
the period of inflation is sometimes required to check
for positioning during inflation of the device balloon.
Although intraoperative 3D CT images can be ob-
tained during rapid fluoroscopic rotation imaging with
contrast injections of the root, such as with the Dyna
CT (Siemens, Erlangen, Germany), these images are
still not accurate enough when no calcium landmarks
are available or registry points are present. Undoubt-
edly, the technology will improve over time and enable
the generation of intraprocedural rotational CT-like
images to help with placement. Use of fluoroscopy
requires contrast dye, but intraoperative dose can be
reduced considerably with proper planning by rou-
tinely pre-operatively obtaining the best angle of the
aortic root and the nadir of the sinuses both during
coronary catheterization and pre-operative root CT
angiography with 3D reconstruction (6).
Is one better than the other in telling whether the
cup is half full or half empty? Clearly, depending on
the circumstances, one might be more useful than
the other, and they should not be considered
mutually exclusive but complementary, ensuring
valve positioning is accurate. Will changes in device
design influence the choice of imaging modality in ithe future? Better radiographic markers on the
deployment balloon and the current stainless steel
cage and new chromium carbide valves certainly
would help, but so would having echocardiographic
contrast media in the device or balloon or in the
inflation liquid. Bubbles in the injection medium
are seen during inflation on echocardiography dur-
ing the balloon valvuloplasty, but this does not
really help with positioning. Although we continue
to use 3D imaging to look at the device in relation
to the leaflets in the aortic root before deployment,
we have not found this reliable enough, because of
the leaflet thickness or calcium. Also, it is often
difficult to visualize the crimped valve over the balloon,
particularly in cases with heavy aortic root calcifica-
tion. Clearly, the imaging techniques are complemen-
tary and increase the confidence in valve placement
when used together. It is obvious that without fluo-
roscopy, the entire procedure is infeasible; in other
words, the procedures have to be done in suites with
proper radiographic equipment for the near future.
TEE is helpful for accurate device placement, but
more importantly it is also used to monitor, identify,
prevent, and manage complications. In most cases,
fluoroscopy with radiographic contrast is the leading
technique, with the role of TEE being principally to
assess residual aortic regurgitation and perivalvular
leakage. Severe regurgitation is less common, and an
argument can be made for not using TEE but rather
intracardiac echocardiography or transthoracic echo-
cardiography, and hence some centers in Europe forgo
TEE, particularly when patients are only sedated for
procedures.
In this issue of iJACC, Bagur et al. (1) present their
xperience by comparing radiographically placed
alves with C-arms against TEE placement, and they
dvocate positioning by primarily TEE. Of note, the
opulation that they deal with is somewhat different
rom the other TAVI populations. The patients are
ounger (79 years of age), have lower Society of
horacic Surgeons score (8.5%) and European System
or Cardiac Operative Risk Evaluation score (25.8%),
nd are smaller and therefore likely to have a smaller
alve area with less calcium than a larger person. None
re reported to have either a porcelain aorta or radia-
ion heart disease or mitral annular calcification, which
re associated more often with heavy calcification or
orcelain aortas. Thus, for the population of the
uebec group, TEE imaging might have been more
seful. Indeed, none of the submitted images show
uch calcium on the radiographic studies. The Que-
ec group C-arm imaging might also have been
nadequate for positioning of devices. Better radio-
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127graphic imaging, including dedicated room fluoro-
scopic imaging, might have prevented the left main
artery occlusion problems they experienced, and they
could have better dealt with the other problems; for
example, putting a wire in a coronary artery before
deployment of the device can be used for coronary
procedures. The obvious question is whether reliance
on TEE affected outcome—particularly on malposi-
tioning—and associated complications, which oc-
curred in 12% of their patients in both groups (em-
bolization, malposition, coronary occlusion, and the
like). These malposition problems could likely have
been reduced with proper radiographic imaging with
state-of-the-art (biplane or robotic) systems in a hy-
brid procedure operating room or a catheterization
lab. Hence, the call for use of only TEE is question-
able, and similarly, the need for a randomized trial is
not justified. The only potential benefit from using
TEE alone is that of cost and possibly to avoid the
complication of renal failure, although none occurred
in their radiographic group and only 1 occurred in the
TEE group. Clearly when newer procedures are a
combination of both percutaneous coronary interven-
tion and TAVI, then dye contrast load will become a
greater issue, as likely will radiation dose. Currently
this is not a problem. It is prudent to be extremely
judicious about the use of radiographic contrast, but a
small amount necessary for visualization of aortic root
during implantation should be tolerated by most
patients. Another peculiarity of the study group was
that prevalence of mitral valve regurgitation was much
more common in the TEE group. Whether this was
related to the selection of patients or the increasing
enrollment of patients with severe mitral valve regur-
gitation in their transapical group remains unclear.
Nonetheless, in the Partner B study, those patients
with severe mitral valve regurgitation had the most
benefit out to 1 year as assessed by the relative risk
analysis (3).
Ultimately, we have been strong advocates of theSurg 2006;82:110–6.
3
4
5. Gurvitch R, Wood D
Transcatheter aorticthis applies also to imaging. We consider both TEE
and radiographic techniques to be essential. Whether
biplane is required or a robotic arm is better is still
debatable. We believe diligent preparation with both
pre-operative CT of the root and root aortography,
intraoperative TEE, and fluoroscopic imaging in a
hybrid operation room is essential for the best possible
result. Indeed, in just under 100 transfemoral TAVI
patients, we have had excellent results and no patient
requiring dialysis, and for 40 transapical TAVI pa-
tients our operative mortality has been low, with 1
renal failure. We thus continue to believe that, as long
as cost is not the issue, better results will be obtained
by a combination of both sound waves and radiation
beams. Undoubtedly with fusion of echocardiographic
and radiographic imaging and newer devices that
make positioning easier and more controlled, compli-
cations from malpositioned devices should decline.
Furthermore, these modalities will continue to be
complementary and additive for newer mitral valve
devices, endovascular aortic procedures, and other
procedures.
In summary, although it is provocative to rely on
only 1 imaging modality (TEE in this case, and
many other reports suggesting radiography as the
only imaging modality), it does not make practical
sense to close “one eye” to assess whether the cup is
half full during the procedure in the environment
where we are trying to perfect a new technique and
potentially make it applicable for low-risk patients.
It would be prudent to use all our imaging power to
make the procedure as safe as possible for the
current devices, particularly in centers that are
commencing their use. With the advent of newer
devices and more experience, more focus can be
directed toward the cost of the procedure.
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